Important change to Heparin Potency - FDA

The Food and Drug Administration has announced that a new reference standard resulting from the heparin contamination issue last year will lead to about a 10% reduction in actual potency. This may affect your dosing of heparin in the perioperative period for vascular, cardiac and other procedures.

For more information, see this press release at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm184502.htm.